Post-doctoral Fellow at Peking University China Center for Health Development Studies

Education Background

2019-2024, Ph.D., Social Medicine and Health Service Management, School of Public Health, Peking University

2022-2023, visiting Ph.D., Health Economics, Health Economics Research Centre (HERC), Nuffield Department of Population Health, University of Oxford

2015-2019, B.Ec., Economics, National School of Development (NSD), Peking University

2014-2019, B.A., Biomedical English, School of Health Humanities, Peking University

Research Interest

Health economic evaluation

Infectious disease epidemiology

Evidence-based decision-making in vaccination

Selected Peer-reviewed Publications

English

Zhang H*, Lai X*, Patenaude BN, et al. Adding new childhood vaccines to China’s National Immunization Program: evidence, benefits, and priorities. Lancet Public Health. 2023; 8(12):e1016-e1024.

Lai X*, Zhang H*, Pouwels KB, et al. Estimating global and regional between-country inequality in routine childhood vaccine coverage in 195 countries and territories from 2019 to 2021: a longitudinal study. eClinicalMedicine. 2023; 60:102042.

Lai X*, Yuan Y*, Wang H, et al. Cost-effectiveness of salt substitute and salt supply restriction in eldercare facilities: the DECIDE-Salt cluster randomized clinical trial. JAMA Network Open. 2024; 7(2):e2355564.

Lai X, Ma Y, Fang H. Better adherence to childhood Haemophilus influenzae type b vaccination with combination vaccines compared to single-antigen vaccines: evidence from China. Journal of Global Health. 2023; 13:04080.

Lyu Y*, Lai X*, Ma Y, et al. Factors associated with the recommendation of four non-National Immunization Program vaccines: a cross-sectional survey among public health workers in China. Infectous Diseases of Poverty. 2023;12(1):91.

Lai X*, Wahl B*, Yu W*, et al. National, regional, and provincial disease burden attributed to Streptococcus pneumoniae and Haemophilus influenzae type b in children in China: modelled estimates for 2010-17. Lancet Regional Health-Western Pacific. 2022; 22, 100430.

Lai X*, Garcia C*, Wu D*, et al. Estimating national, regional and provincial cost-effectiveness of introducing childhood 13-valent pneumococcal conjugate vaccination in China: a modelling analysis. Lancet Regional Health-Western Pacific. 2022; 32:100666.

Lai X*, Lyu, Y*, Zhang H, et al. PPSV-23 recommendation and vaccination in China: a cross-sectional survey among healthcare workers, older adults and chronic disease patients. Expert Review of Vaccines. 2022; 21(9), 1343-1353.

Lai X, Rong H, Ma X, et al. Willingness to pay for seasonal influenza vaccination among children, chronic disease patients, and the elderly in China: a national cross-sectional survey. Vaccines (Basel). 2020; 8(3), 405.

Lai X*, Zhu H*, Wang J, et al. Public perceptions and acceptance of COVID-19 booster vaccination in China: a cross-sectional study. Vaccines (Basel). 2021; 9(12), 1461.

Hou Z*, Lai X*, Liu Y, et al. Impact of the 2018 Changchun Changsheng vaccine incident on childhood vaccination in China: evidence from vaccination records. Communications Medicine. 2023; 3(1):114.

Lai X*, Li M*, Hou Z, et al. Factors associated with caregivers' hesitancy to vaccinate children against influenza: a cross-sectional survey in China. Vaccine. 2022; 40(29), 3975-3983.

Chinese

Lai X, Fang H. Immunization schedules and financing strategies in the U.S., the U.K., Germany and Japan and their experience for China. National Medical Journal of China 2020, 100(02): 85-89.

Lai X, Peng Z, Qin Y, et al. Financing strategies and cost estimates of influenza vaccination for the elderly in China: explore a multi-party co-payment mechanism. National Medical Journal of China 2021, 101(26): 2029-36.